These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


492 related items for PubMed ID: 19901028

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Autophagy blockade sensitizes the anticancer activity of CA-4 via JNK-Bcl-2 pathway.
    Li Y, Luo P, Wang J, Dai J, Yang X, Wu H, Yang B, He Q.
    Toxicol Appl Pharmacol; 2014 Jan 15; 274(2):319-27. PubMed ID: 24321340
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity.
    Cao Y, Shen T, Huang X, Lin Y, Chen B, Pang J, Li G, Wang Q, Zohrabian S, Duan C, Ruan Y, Man Y, Wang S, Li J.
    Oncotarget; 2017 Jan 17; 8(3):4837-4848. PubMed ID: 27902477
    [Abstract] [Full Text] [Related]

  • 25. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.
    Venkatesan B, Prabhu SD, Venkatachalam K, Mummidi S, Valente AJ, Clark RA, Delafontaine P, Chandrasekar B.
    Cell Signal; 2010 May 17; 22(5):809-20. PubMed ID: 20074638
    [Abstract] [Full Text] [Related]

  • 26. ARC is a critical cardiomyocyte survival switch in doxorubicin cardiotoxicity.
    An J, Li P, Li J, Dietz R, Donath S.
    J Mol Med (Berl); 2009 Apr 17; 87(4):401-10. PubMed ID: 19139834
    [Abstract] [Full Text] [Related]

  • 27. Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression.
    Lv X, Yu X, Wang Y, Wang F, Li H, Wang Y, Lu D, Qi R, Wang H.
    PLoS One; 2012 Apr 17; 7(10):e47351. PubMed ID: 23077597
    [Abstract] [Full Text] [Related]

  • 28. Berbamine postconditioning protects the heart from ischemia/reperfusion injury through modulation of autophagy.
    Zheng Y, Gu S, Li X, Tan J, Liu S, Jiang Y, Zhang C, Gao L, Yang HT.
    Cell Death Dis; 2017 Feb 02; 8(2):e2577. PubMed ID: 28151484
    [Abstract] [Full Text] [Related]

  • 29. Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways.
    Mantawy EM, Esmat A, El-Bakly WM, Salah ElDin RA, El-Demerdash E.
    Sci Rep; 2017 Jul 06; 7(1):4795. PubMed ID: 28684738
    [Abstract] [Full Text] [Related]

  • 30. Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: comparison with osteosarcoma cells.
    Tacar O, Indumathy S, Tan ML, Baindur-Hudson S, Friedhuber AM, Dass CR.
    J Pharm Pharmacol; 2015 Feb 06; 67(2):231-43. PubMed ID: 25208656
    [Abstract] [Full Text] [Related]

  • 31. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes.
    Asensio-Lopez MC, Sanchez-Mas J, Pascual-Figal DA, de Torre C, Valdes M, Lax A.
    Free Radic Biol Med; 2014 Feb 06; 67():19-29. PubMed ID: 24231192
    [Abstract] [Full Text] [Related]

  • 32. MiRNA-30e mediated cardioprotection of ACE2 in rats with Doxorubicin-induced heart failure through inhibiting cardiomyocytes autophagy.
    Lai L, Chen J, Wang N, Zhu G, Duan X, Ling F.
    Life Sci; 2017 Jan 15; 169():69-75. PubMed ID: 27633839
    [Abstract] [Full Text] [Related]

  • 33. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
    Wang X, Wang XL, Chen HL, Wu D, Chen JX, Wang XX, Li RL, He JH, Mo L, Cen X, Wei YQ, Jiang W.
    Biochem Pharmacol; 2014 Apr 01; 88(3):334-50. PubMed ID: 24522112
    [Abstract] [Full Text] [Related]

  • 34. CO and bilirubin inhibit doxorubicin-induced cardiac cell death.
    Kim DS, Chae SW, Kim HR, Chae HJ.
    Immunopharmacol Immunotoxicol; 2009 Apr 01; 31(1):64-70. PubMed ID: 18756386
    [Abstract] [Full Text] [Related]

  • 35. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity.
    Jing X, Yang J, Jiang L, Chen J, Wang H.
    Cell Physiol Biochem; 2018 Apr 01; 48(2):692-704. PubMed ID: 30025410
    [Abstract] [Full Text] [Related]

  • 36. Curcumin inhibits autophagy and apoptosis in hypoxia/reoxygenation-induced myocytes.
    Huang Z, Ye B, Dai Z, Wu X, Lu Z, Shan P, Huang W.
    Mol Med Rep; 2015 Jun 01; 11(6):4678-84. PubMed ID: 25673156
    [Abstract] [Full Text] [Related]

  • 37. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
    Jia Y, Zuo D, Li Z, Liu H, Dai Z, Cai J, Pang L, Wu Y.
    Chem Pharm Bull (Tokyo); 2014 Jun 01; 62(1):45-53. PubMed ID: 24390491
    [Abstract] [Full Text] [Related]

  • 38. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
    Pandey S, Kuo WW, Shen CY, Yeh YL, Ho TJ, Chen RJ, Chang RL, Pai PY, Viswanadha VP, Huang CY, Huang CY.
    Am J Physiol Cell Physiol; 2019 Aug 01; 317(2):C235-C243. PubMed ID: 31116582
    [Abstract] [Full Text] [Related]

  • 39. Diminished GATA4 protein levels contribute to hyperglycemia-induced cardiomyocyte injury.
    Kobayashi S, Mao K, Zheng H, Wang X, Patterson C, O'Connell TD, Liang Q.
    J Biol Chem; 2007 Jul 27; 282(30):21945-52. PubMed ID: 17525155
    [Abstract] [Full Text] [Related]

  • 40. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
    Ludke A, Akolkar G, Ayyappan P, Sharma AK, Singal PK.
    PLoS One; 2017 Jul 27; 12(7):e0179452. PubMed ID: 28678856
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 25.